APO Research

APO RESEARCH · REPORT

Melphalan Injection

Selected research

Market Analysis & Forecast

Global Melphalan Injection Market Analysis and Forecast 2026-2032

Market perspective

The global Melphalan Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Melphalan Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Melphalan Injection include Athenex, Dr. Reddy's, Mediclone Biotech, Meitheal Pharmaceutical, Par Pharmaceuticals, Sagent, Spectrum Pharmaceuticals, Fresenius Kabi and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Melphalan Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Melphalan Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Melphalan Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Melphalan Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Melphalan Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Melphalan Injection sales, projected growth trends, production technology, application and end-user industry.

Melphalan Injection Segment by Company

Athenex

Dr. Reddy's

Mediclone Biotech

Meitheal Pharmaceutical

Par Pharmaceuticals

Sagent

Spectrum Pharmaceuticals

Fresenius Kabi

GSK

Mylan

Melphalan Injection Segment by Type

50mg/vial

10mg/vial

Melphalan Injection Segment by Application

Recovery Center

Hospital

Clinics

Melphalan Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melphalan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melphalan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melphalan Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Melphalan Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Melphalan Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melphalan Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Melphalan Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg/vial Major Manufacturers Table 3. 10mg/vial Major Manufacturers Table 4. Global Melphalan Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Recovery Center Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Clinics Major Manufacturers Table 8. Melphalan Injection Industry Trends Table 9. Melphalan Injection Industry Drivers Table 10. Melphalan Injection Industry Opportunities and Challenges Table 11. Melphalan Injection Industry Restraints Table 12. Global Melphalan Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Melphalan Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Melphalan Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Melphalan Injection Revenue Market Share by Region (2021-2026) Table 16. Global Melphalan Injection Revenue Market Share by Region (2027-2032) Table 17. Global Melphalan Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Melphalan Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Melphalan Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Melphalan Injection Sales Market Share by Region (2021-2026) Table 21. Global Melphalan Injection Sales Market Share by Region (2027-2032) Table 22. Global Melphalan Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Melphalan Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Melphalan Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Melphalan Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Melphalan Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Melphalan Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Melphalan Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Melphalan Injection Manufacturers, Product Type & Application Table 30. Global Melphalan Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Melphalan Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Melphalan Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Melphalan Injection Revenue Market Share by Type (2021-2026) Table 37. Global Melphalan Injection Revenue Market Share by Type (2027-2032) Table 38. Global Melphalan Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Melphalan Injection Sales Market Share by Type (2021-2026) Table 42. Global Melphalan Injection Sales Market Share by Type (2027-2032) Table 43. Global Melphalan Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Melphalan Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Melphalan Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Melphalan Injection Revenue Market Share by Application (2021-2026) Table 49. Global Melphalan Injection Revenue Market Share by Application (2027-2032) Table 50. Global Melphalan Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Melphalan Injection Sales Market Share by Application (2021-2026) Table 54. Global Melphalan Injection Sales Market Share by Application (2027-2032) Table 55. Global Melphalan Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Melphalan Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Athenex Company Information Table 58. Athenex Business Overview Table 59. Athenex Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Athenex Melphalan Injection Product Portfolio Table 61. Athenex Recent Development Table 62. Dr. Reddy's Company Information Table 63. Dr. Reddy's Business Overview Table 64. Dr. Reddy's Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Dr. Reddy's Melphalan Injection Product Portfolio Table 66. Dr. Reddy's Recent Development Table 67. Mediclone Biotech Company Information Table 68. Mediclone Biotech Business Overview Table 69. Mediclone Biotech Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Mediclone Biotech Melphalan Injection Product Portfolio Table 71. Mediclone Biotech Recent Development Table 72. Meitheal Pharmaceutical Company Information Table 73. Meitheal Pharmaceutical Business Overview Table 74. Meitheal Pharmaceutical Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Meitheal Pharmaceutical Melphalan Injection Product Portfolio Table 76. Meitheal Pharmaceutical Recent Development Table 77. Par Pharmaceuticals Company Information Table 78. Par Pharmaceuticals Business Overview Table 79. Par Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Par Pharmaceuticals Melphalan Injection Product Portfolio Table 81. Par Pharmaceuticals Recent Development Table 82. Sagent Company Information Table 83. Sagent Business Overview Table 84. Sagent Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sagent Melphalan Injection Product Portfolio Table 86. Sagent Recent Development Table 87. Spectrum Pharmaceuticals Company Information Table 88. Spectrum Pharmaceuticals Business Overview Table 89. Spectrum Pharmaceuticals Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Spectrum Pharmaceuticals Melphalan Injection Product Portfolio Table 91. Spectrum Pharmaceuticals Recent Development Table 92. Fresenius Kabi Company Information Table 93. Fresenius Kabi Business Overview Table 94. Fresenius Kabi Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Fresenius Kabi Melphalan Injection Product Portfolio Table 96. Fresenius Kabi Recent Development Table 97. GSK Company Information Table 98. GSK Business Overview Table 99. GSK Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GSK Melphalan Injection Product Portfolio Table 101. GSK Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Melphalan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan Melphalan Injection Product Portfolio Table 106. Mylan Recent Development Table 107. North America Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 110. North America Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 111. North America Melphalan Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America Melphalan Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 116. North America Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 117. North America Melphalan Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America Melphalan Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Melphalan Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Melphalan Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Melphalan Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 124. North America Melphalan Injection Sales by Country (2027-2032) & (K Units) Table 125. North America Melphalan Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America Melphalan Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 128. Canada Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 129. Europe Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 132. Europe Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 133. Europe Melphalan Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe Melphalan Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 138. Europe Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 139. Europe Melphalan Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe Melphalan Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Melphalan Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe Melphalan Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe Melphalan Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 146. Europe Melphalan Injection Sales by Country (2027-2032) & (K Units) Table 147. Europe Melphalan Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe Melphalan Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 150. France Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 151. U.K. Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 152. Italy Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 154. Nordic Countries Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 155. China Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 156. China Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 157. China Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 158. China Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 159. China Melphalan Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Melphalan Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 162. China Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 163. China Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 164. China Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 165. China Melphalan Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Melphalan Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 170. Asia Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 171. Asia Melphalan Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Melphalan Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 176. Asia Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 177. Asia Melphalan Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Melphalan Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Melphalan Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Melphalan Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Melphalan Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. Asia Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 184. Asia Melphalan Injection Sales by Country (2027-2032) & (K Units) Table 185. Asia Melphalan Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Melphalan Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 188. South Korea Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 189. India Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 190. Australia Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 191. China Taiwan Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Melphalan Injection Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Melphalan Injection Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Melphalan Injection Sales by Type (2021-2026) & (K Units) Table 196. SAMEA Melphalan Injection Sales by Type (2027-2032) & (K Units) Table 197. SAMEA Melphalan Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Melphalan Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Melphalan Injection Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Melphalan Injection Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Melphalan Injection Sales by Application (2021-2026) & (K Units) Table 202. SAMEA Melphalan Injection Sales by Application (2027-2032) & (K Units) Table 203. SAMEA Melphalan Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Melphalan Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Melphalan Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Melphalan Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Melphalan Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. SAMEA Melphalan Injection Sales by Country (2021-2026) & (K Units) Table 210. SAMEA Melphalan Injection Sales by Country (2027-2032) & (K Units) Table 211. SAMEA Melphalan Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Melphalan Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 214. Argentina Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 215. Chile Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 216. Colombia Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 217. Peru Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 219. Israel Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 220. UAE Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 221. Turkey Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 222. Iran Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 223. Egypt Melphalan Injection Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Melphalan Injection Distributors List Table 227. Melphalan Injection Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Melphalan Injection Image Figure 2. Global Melphalan Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melphalan Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg/vial Image Figure 5. 10mg/vial Image Figure 6. Global Melphalan Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Melphalan Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Recovery Center Image Figure 9. Hospital Image Figure 10. Clinics Image Figure 11. Global Melphalan Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Melphalan Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Melphalan Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Melphalan Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Melphalan Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Melphalan Injection Sales (2021-2032) & (K Units) Figure 17. Global Melphalan Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Melphalan Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Melphalan Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Melphalan Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Melphalan Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Melphalan Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Melphalan Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Melphalan Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Melphalan Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Melphalan Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Melphalan Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Melphalan Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Melphalan Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Melphalan Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Melphalan Injection Sales Market Share by Type (2021-2032) Figure 33. Global Melphalan Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Melphalan Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Melphalan Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Melphalan Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Melphalan Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Melphalan Injection Sales Market Share by Application (2021-2032) Figure 39. North America Melphalan Injection Revenue Share by Type (2021-2032) Figure 40. North America Melphalan Injection Sales Share by Type (2021-2032) Figure 41. North America Melphalan Injection Revenue Share by Application (2021-2032) Figure 42. North America Melphalan Injection Sales Share by Application (2021-2032) Figure 43. North America Melphalan Injection Revenue Share by Country (2021-2032) Figure 44. North America Melphalan Injection Sales Share by Country (2021-2032) Figure 45. Europe Melphalan Injection Revenue Share by Type (2021-2032) Figure 46. Europe Melphalan Injection Sales Share by Type (2021-2032) Figure 47. Europe Melphalan Injection Revenue Share by Application (2021-2032) Figure 48. Europe Melphalan Injection Sales Share by Application (2021-2032) Figure 49. Europe Melphalan Injection Revenue Share by Country (2021-2032) Figure 50. Europe Melphalan Injection Sales Share by Country (2021-2032) Figure 51. China Melphalan Injection Revenue Share by Type (2021-2032) Figure 52. China Melphalan Injection Sales Share by Type (2021-2032) Figure 53. China Melphalan Injection Revenue Share by Application (2021-2032) Figure 54. China Melphalan Injection Sales Share by Application (2021-2032) Figure 55. Asia Melphalan Injection Revenue Share by Type (2021-2032) Figure 56. Asia Melphalan Injection Sales Share by Type (2021-2032) Figure 57. Asia Melphalan Injection Revenue Share by Application (2021-2032) Figure 58. Asia Melphalan Injection Sales Share by Application (2021-2032) Figure 59. Asia Melphalan Injection Revenue Share by Country (2021-2032) Figure 60. Asia Melphalan Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Melphalan Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Melphalan Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Melphalan Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Melphalan Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Melphalan Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Melphalan Injection Sales Share by Country (2021-2032) Figure 67. Melphalan Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Melphalan Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/vial
  • 10mg/vial
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • Athenex
  • Dr. Reddy's
  • Mediclone Biotech
  • Meitheal Pharmaceutical
  • Par Pharmaceuticals
  • Sagent
  • Spectrum Pharmaceuticals
  • Fresenius Kabi
  • GSK
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Melphalan Injection Market by Type
  3. 1.2.1 Global Melphalan Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg/vial
  5. 1.2.3 10mg/vial
  6. 1.3 Melphalan Injection Market by Application
  7. 1.3.1 Global Melphalan Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Recovery Center
  9. 1.3.3 Hospital
  10. 1.3.4 Clinics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Melphalan Injection Market Dynamics
  1. 2.1 Melphalan Injection Industry Trends
  2. 2.2 Melphalan Injection Industry Drivers
  3. 2.3 Melphalan Injection Industry Opportunities and Challenges
  4. 2.4 Melphalan Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Melphalan Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Melphalan Injection Revenue by Region
  3. 3.2.1 Global Melphalan Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Melphalan Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Melphalan Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Melphalan Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Melphalan Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Melphalan Injection Sales by Region
  9. 3.4.1 Global Melphalan Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Melphalan Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Melphalan Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Melphalan Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Melphalan Injection Revenue by Manufacturers
  2. 4.1.1 Global Melphalan Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Melphalan Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Melphalan Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Melphalan Injection Sales by Manufacturers
  6. 4.2.1 Global Melphalan Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Melphalan Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Melphalan Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Melphalan Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Melphalan Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Melphalan Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Melphalan Injection Manufacturers, Product Type & Application
  13. 4.7 Global Melphalan Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Melphalan Injection Market CR5 and HHI
  16. 4.8.2 2025 Melphalan Injection Tier 1, Tier 2, and Tier 3
5 Melphalan Injection Market by Type
  1. 5.1 Global Melphalan Injection Revenue by Type
  2. 5.1.1 Global Melphalan Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Melphalan Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Melphalan Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Melphalan Injection Sales by Type
  6. 5.2.1 Global Melphalan Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Melphalan Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Melphalan Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Melphalan Injection Price by Type
6 Melphalan Injection Market by Application
  1. 6.1 Global Melphalan Injection Revenue by Application
  2. 6.1.1 Global Melphalan Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Melphalan Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Melphalan Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Melphalan Injection Sales by Application
  6. 6.2.1 Global Melphalan Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Melphalan Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Melphalan Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Melphalan Injection Price by Application
7 Company Profiles
  1. 7.1 Athenex
  2. 7.1.1 Athenex Company Information
  3. 7.1.2 Athenex Business Overview
  4. 7.1.3 Athenex Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Athenex Melphalan Injection Product Portfolio
  6. 7.1.5 Athenex Recent Developments
  7. 7.2 Dr. Reddy's
  8. 7.2.1 Dr. Reddy's Company Information
  9. 7.2.2 Dr. Reddy's Business Overview
  10. 7.2.3 Dr. Reddy's Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dr. Reddy's Melphalan Injection Product Portfolio
  12. 7.2.5 Dr. Reddy's Recent Developments
  13. 7.3 Mediclone Biotech
  14. 7.3.1 Mediclone Biotech Company Information
  15. 7.3.2 Mediclone Biotech Business Overview
  16. 7.3.3 Mediclone Biotech Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mediclone Biotech Melphalan Injection Product Portfolio
  18. 7.3.5 Mediclone Biotech Recent Developments
  19. 7.4 Meitheal Pharmaceutical
  20. 7.4.1 Meitheal Pharmaceutical Company Information
  21. 7.4.2 Meitheal Pharmaceutical Business Overview
  22. 7.4.3 Meitheal Pharmaceutical Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Meitheal Pharmaceutical Melphalan Injection Product Portfolio
  24. 7.4.5 Meitheal Pharmaceutical Recent Developments
  25. 7.5 Par Pharmaceuticals
  26. 7.5.1 Par Pharmaceuticals Company Information
  27. 7.5.2 Par Pharmaceuticals Business Overview
  28. 7.5.3 Par Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Par Pharmaceuticals Melphalan Injection Product Portfolio
  30. 7.5.5 Par Pharmaceuticals Recent Developments
  31. 7.6 Sagent
  32. 7.6.1 Sagent Company Information
  33. 7.6.2 Sagent Business Overview
  34. 7.6.3 Sagent Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sagent Melphalan Injection Product Portfolio
  36. 7.6.5 Sagent Recent Developments
  37. 7.7 Spectrum Pharmaceuticals
  38. 7.7.1 Spectrum Pharmaceuticals Company Information
  39. 7.7.2 Spectrum Pharmaceuticals Business Overview
  40. 7.7.3 Spectrum Pharmaceuticals Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Spectrum Pharmaceuticals Melphalan Injection Product Portfolio
  42. 7.7.5 Spectrum Pharmaceuticals Recent Developments
  43. 7.8 Fresenius Kabi
  44. 7.8.1 Fresenius Kabi Company Information
  45. 7.8.2 Fresenius Kabi Business Overview
  46. 7.8.3 Fresenius Kabi Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Fresenius Kabi Melphalan Injection Product Portfolio
  48. 7.8.5 Fresenius Kabi Recent Developments
  49. 7.9 GSK
  50. 7.9.1 GSK Company Information
  51. 7.9.2 GSK Business Overview
  52. 7.9.3 GSK Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GSK Melphalan Injection Product Portfolio
  54. 7.9.5 GSK Recent Developments
  55. 7.10 Mylan
  56. 7.10.1 Mylan Company Information
  57. 7.10.2 Mylan Business Overview
  58. 7.10.3 Mylan Melphalan Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mylan Melphalan Injection Product Portfolio
  60. 7.10.5 Mylan Recent Developments
8 North America
  1. 8.1 North America Melphalan Injection Market Size by Type
  2. 8.1.1 North America Melphalan Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Melphalan Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Melphalan Injection Price by Type (2021-2032)
  5. 8.2 North America Melphalan Injection Market Size by Application
  6. 8.2.1 North America Melphalan Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Melphalan Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Melphalan Injection Price by Application (2021-2032)
  9. 8.3 North America Melphalan Injection Market Size by Country
  10. 8.3.1 North America Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Melphalan Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Melphalan Injection Market Size by Type
  2. 9.1.1 Europe Melphalan Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Melphalan Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Melphalan Injection Price by Type (2021-2032)
  5. 9.2 Europe Melphalan Injection Market Size by Application
  6. 9.2.1 Europe Melphalan Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Melphalan Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Melphalan Injection Price by Application (2021-2032)
  9. 9.3 Europe Melphalan Injection Market Size by Country
  10. 9.3.1 Europe Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Melphalan Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Melphalan Injection Market Size by Type
  2. 10.1.1 China Melphalan Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Melphalan Injection Sales by Type (2021-2032)
  4. 10.1.3 China Melphalan Injection Price by Type (2021-2032)
  5. 10.2 China Melphalan Injection Market Size by Application
  6. 10.2.1 China Melphalan Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Melphalan Injection Sales by Application (2021-2032)
  8. 10.2.3 China Melphalan Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Melphalan Injection Market Size by Type
  2. 11.1.1 Asia Melphalan Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Melphalan Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Melphalan Injection Price by Type (2021-2032)
  5. 11.2 Asia Melphalan Injection Market Size by Application
  6. 11.2.1 Asia Melphalan Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Melphalan Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Melphalan Injection Price by Application (2021-2032)
  9. 11.3 Asia Melphalan Injection Market Size by Country
  10. 11.3.1 Asia Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Melphalan Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Melphalan Injection Market Size by Type
  2. 12.1.1 SAMEA Melphalan Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Melphalan Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Melphalan Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Melphalan Injection Market Size by Application
  6. 12.2.1 SAMEA Melphalan Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Melphalan Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Melphalan Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Melphalan Injection Market Size by Country
  10. 12.3.1 SAMEA Melphalan Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Melphalan Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Melphalan Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Melphalan Injection Value Chain Analysis
  2. 13.1.1 Melphalan Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Melphalan Injection Production Mode & Process
  6. 13.2 Melphalan Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Melphalan Injection Distributors
  9. 13.2.3 Melphalan Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research